Evidence map›Paper›PMID 34207442›Full record

ArticleJournal of clinical medicine2021

Prognostic and Pathophysiologic Significance of IL-8 (CXCL8) in Biliary Atresia.

Nimish Godbole, Iiris Nyholm, Maria Hukkinen, Joseph R Davidson, Athanasios Tyraskis, Katja Eloranta, Noora Andersson, Jouko Lohi, Päivi Heikkilä, Antti Kyrönlahti and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biliary atresia.Nature reviews. Disease primers · 2024
    Review
  5. Progress in Biomarkers Related to Biliary Atresia.Journal of clinical and translational hepatology · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. The immunological function of CXCR2 in the liver during sepsis.Journal of inflammation (London, England) · 2022
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 3 countries.

Nimish GodbolePediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.ORCID 0000-0002-1606-3028
Iiris NyholmPediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.
Maria HukkinenPediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.
Joseph R DavidsonDepartment of Pediatric Surgery, GOS-UCL Institute of Child Health, London WC1N 1EH, UK.
Athanasios TyraskisDepartment of Pediatric Surgery, King's College Hospital, London SE5 9RS, UK.
Katja ElorantaPediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.
Noora AnderssonPediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.
Jouko LohiDepartment of Pathology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.
Päivi HeikkiläDepartment of Pathology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.
Antti KyrönlahtiPediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.ORCID 0000-0001-5271-2366
Marjut PihlajokiPediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.
Mark DavenportDepartment of Pediatric Surgery, King's College Hospital, London SE5 9RS, UK.
Markku HeikinheimoPediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.ORCID 0000-0001-9452-0661
Mikko P PakarinenPediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.ORCID 0000-0001-6016-6334
University of Helsinki · FIKing's College Hospital · GB

Funding

Finska LäkaresällskapetHelsingin ja Uudenmaan SairaanhoitopiiriLastentautien TutkimussäätiöSigrid Juséliuksen Säätiö
6 · The paper itself

Abstract

Interleukin (IL)-8 (CXCL8), a chemokine involved in neutrophil recruitment, has been implicated in ductular reaction and liver fibrogenesis. We studied liver and serum IL-8 expression in a large biliary atresia (BA) cohort and explored its prognostic and pathophysiological potential. IL-8 expression was assessed in liver utilizing quantitative polymerase chain reaction (qPCR), immunohistochemistry and in situ hybridization and in serum using an enzyme-linked immunosorbent assay, among 115 BA patients, 10 disease controls and 68 normal controls. Results were correlated to portoenterostomy (PE) outcomes, biochemical and histological liver injury, transcriptional markers of fibrosis and cholangiocytes, and expression of other related cytokines. IL-8 was markedly overexpressed in liver and serum of BA patients at PE (

Indexed as

biomarkercholangiocyteductular reactionliver fibrosispediatric liver disease

Identifiers

PMID34207442
PMCPMC8234515
OpenAlexW3174607197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.